Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Filaggrin loss-of-function mutations, atopic dermatitis and risk of actinic keratosis: results from two cross-sectional studies.

Andersen YMF, Egeberg A, Balslev E, Jørgensen CLT, Szecsi PB, Stender S, Kaae J, Linneberg A, Gislason G, Skov L, Elias PM, Thyssen JP.

J Eur Acad Dermatol Venereol. 2017 Jun;31(6):1038-1043. doi: 10.1111/jdv.14172. Epub 2017 Mar 6.

PMID:
28213896
2.

High-Risk Premenopausal Luminal A Breast Cancer Patients Derive no Benefit from Adjuvant Cyclophosphamide-based Chemotherapy: Results from the DBCG77B Clinical Trial.

Nielsen TO, Jensen MB, Burugu S, Gao D, Jørgensen CL, Balslev E, Ejlertsen B.

Clin Cancer Res. 2017 Feb 15;23(4):946-953. doi: 10.1158/1078-0432.CCR-16-1278. Epub 2016 Sep 6.

3.

TIMP-1 and responsiveness to gemcitabine in advanced breast cancer; results from a randomized phase III trial from the Danish breast cancer cooperative group.

Jørgensen CL, Bjerre C, Ejlertsen B, Bjerre KD, Balslev E, Bartels A, Brünner N, Nielsen DL.

BMC Cancer. 2014 May 22;14:360. doi: 10.1186/1471-2407-14-360.

4.

PAM50 breast cancer intrinsic subtypes and effect of gemcitabine in advanced breast cancer patients.

Jørgensen CL, Nielsen TO, Bjerre KD, Liu S, Wallden B, Balslev E, Nielsen DL, Ejlertsen B.

Acta Oncol. 2014 Jun;53(6):776-87. doi: 10.3109/0284186X.2013.865076. Epub 2013 Dec 20.

PMID:
24359601
5.

Gene aberrations of RRM1 and RRM2B and outcome of advanced breast cancer after treatment with docetaxel with or without gemcitabine.

Jørgensen CL, Ejlertsen B, Bjerre KD, Balslev E, Nielsen DL, Nielsen KV.

BMC Cancer. 2013 Nov 12;13:541. doi: 10.1186/1471-2407-13-541.

6.

Population densities and tree diameter effects associated with verbenone treatments to reduce mountain pine beetle-caused mortality of lodgepole pine.

Progar RA, Blackford DC, Cluck DR, Costello S, Dunning LB, Eager T, Jorgensen CL, Munson AS, Steed B, Rinella MJ.

J Econ Entomol. 2013 Feb;106(1):221-8.

PMID:
23448035
7.

Gemcitabine plus docetaxel versus docetaxel in patients with predominantly human epidermal growth factor receptor 2-negative locally advanced or metastatic breast cancer: a randomized, phase III study by the Danish Breast Cancer Cooperative Group.

Nielsen DL, Bjerre KD, Jakobsen EH, Cold S, Stenbygaard L, Sørensen PG, Kamby C, Møller S, Jørgensen CL, Andersson M.

J Clin Oncol. 2011 Dec 20;29(36):4748-54. doi: 10.1200/JCO.2010.33.9507. Epub 2011 Nov 14.

PMID:
22084374
8.

Saddle block anesthesia for delivery; report of 1,000 cases.

JORGENSEN CL, GRAVES JH, SAVAGE JE.

South Med J. 1948 Sep;41(9):830-4. No abstract available.

PMID:
18879673
9.

Pregnancy and multiple sclerosis.

DOUGLASS LH, JORGENSEN CL.

Am J Obstet Gynecol. 1948 Feb;55(2):332-6. No abstract available.

PMID:
18897954

Supplemental Content

Loading ...
Support Center